(THE AGE) — Australian researchers have found a ”genetic switch” that has the potential to open up new treatments for breast cancer.

The switch allows scientists to change breast cancer cells and make them more responsive to different kinds of treatments, such as anti-oestrogen therapies.

Outlined in the latest edition of the journal PLoS Biology, researchers from the Garvan Institute of Medical Research in Sydney found that the molecule known as ELF5 can turn genes on or off.

Note: Read our discussion guidelines before commenting.